-
Stocks Gaining Momentum: Vale S.A. (NYSE:VALE), American Realty Capital Properties, (NASDAQ:ARCP), Western Digital (NASDAQ:WDC), RXi Pharmaceuticals (NASDAQ:RXII), Fidelity National Information Services (NYSE:FIS)
Vale SA (NYSE:VALE) has received a consensus recommendation of “Hold” from the fifteen ratings firms that are currently covering the company,AnalystRatingsNetwork reports. Five investment analysts have rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company. On Tuesday shares of Vale S.A.…
-
Biotech Stocks Touched New Lows: Synta Pharmaceuticals (NASDAQ:SNTA), Genocea Bioscience (NASDAQ:GNCA), RXi Pharmaceuticals Corporation (NASDAQ:RXII), 22nd Century (NYSEMKT: XXII), Theravance Inc. (NASDAQ:THRX)
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) has received a Neutral rating from research analysts at Zacks with a rank of 3. The company has been rated an average of 3 by 4 Wall Street Analysts. 2 analysts have added the counter in their list of strong buys. 2 market experts have a negative outlook and rated it…
-
NASDAQ Losers: Advanced Micro Devices (NASDAQ:AMD), EnteroMedics Inc. (NASDAQ:ETRM), QAD Inc. (NASDAQ:QADA), Amyris (NASDAQ:AMRS), RXi Pharmaceuticals Corporation (NASDAQ:RXII)
Advanced Micro Devices, Inc. (NASDAQ:AMD) will announce its earnings results on Tuesday, January 20th. On Friday shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) closed at $2.39. Company’s sales growth for last 5 years was -1.80% and EPS growth for next 5 years is recorded as 42.50%. On 14 January EnteroMedics Inc. (NASDAQ:ETRM) received the US…
-
Investor’s Choice: Transocean (NYSE:RIG), Halliburton Company (NYSE:HAL), Ubiquiti Networks (NASDAQ:UBNT), RXi Pharmaceuticals Corporation (NASDAQ:RXII), Omnicare Inc. (NYSE:OCR)
Shares of Transocean LTD (NYSE:RIG) have been given an average rating of “Hold” by the twenty-eight ratings firms that are presently covering the company. Eight research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating on the company. The average 1-year target…
-
Biotech Top Losers: Avalanche Biotechnologies (NASDAQ:AAVL), Sorrento Therapeutics (NASDAQ:SRNE), NeuroDerm (NASDAQ:NDRM), RXi Pharmaceuticals Corporation (NASDAQ:RXII), Vitae Pharmaceuticals (NASDAQ:VTAE)
Shares of Avalanche Biotechnologies (NASDAQ:AAVL) were the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,605,968 shares, an increase of 28.3% from the December 15th total of 1,251,774 shares, AnalystRatings.Net reports. On Friday shares of Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) closed at…
-
Morning Movers: RXi Pharmaceuticals Corporation (NASDAQ:RXII), Banco Santander, S.A. (NYSE:SAN), VIVUS Inc. (NASDAQ:VVUS), Compass Minerals International Inc. (NYSE:CMP), Globus Maritime Limited (NASDAQ:GLBS)
Cauwenbergh Geert, President & CEO of RXi Pharmaceuticals Corp. (NASDAQ:RXII), had purchased 2,500 shares on December 30, 2014. The total value of the transaction was $3,975. The information was disclosed with the SEC in a Form 4 Filing. The information is based on open market trades at the market prices.Option exercises are not covered. On…
-
Biotech Insider Buying: Merrimack Pharmaceuticals (NASDAQ:MACK), Verastem, Vanda Pharmaceuticals (NASDAQ:VNDA), Akebia Therapeutics (NASDAQ:AKBA), RXi Pharmaceuticals Corporation (NASDAQ:RXII)
Merrimack Pharmaceuticals (NASDAQ:MACK) Director Vivian S. Lee acquired 20,000 shares of the stock in a transaction that occurred on Tuesday, December 23rd. The shares were purchased at an average price of $10.23 per share, with a total value of $204,600.00. Following the completion of the purchase, the director now directly owns 20,000 shares of the…
-
Sizzling Stocks: NewLink Genetics Corporation (NASDAQ:NLNK), AOL Inc. (NYSE:AOL), Perficient Inc. (NASDAQ:PRFT), RXi Pharmaceuticals Corporation (NASDAQ:RXII), MAM Software Group (NASDAQ:MAMS)
On 22 December NewLink Genetics Corporation (NASDAQ:NLNK) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced that the Biomedical Advanced Research and Development Authority (BARDA) of the United States Department of Health and Human Services (HHS) has awarded NewLink Genetics’ wholly-owned subsidiary, BioProtection Systems, as the prime contractor in a $30…
-
Hot Watch List: Companhia Siderurgica Nacional (NYSE:SID), RXi Pharmaceuticals Corporation (NASDAQ:RXII), Suburban Propane Partners, L.P. (NYSE:SPH), Alaska Air (NYSE:ALK), W.R. Grace (NYSE:GRA)
Companhia Siderurgica Nacional (NYSE:SID) has been given a “BB” credit rating by analysts at Morningstar. The investment research firm’s “BB” rating indicates that the company is an above-average default risk. They also gave their stock a four star rating. Companhia Siderurgica Nacional (NYSE:SID) in last trading activity decreased -0.45% to close at $2.23. Company weekly…